Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Gastrointestinal protection: BPC-157 was originally discovered in gastric juice and has been shown to protect the gastrointestinal tract from damage caused by various agents, such as NSAIDs (nonsteroidal anti-inflammatory drugs), alcohol, and stress
BPC-157 was placed in Category 2 ("may present significant safety risks") in 2023, removed from that category in April 2026, and is now set for a Pharmacy Compounding Advisory Committee review in late July 2026, while CJC-1295 and Ipamorelin were placed in Category 2 back in October 2023
It is the result of fixed biological differences in body composition, enzyme activity, and the mathematical constants used in alcohol pharmacokinetics
TB-500 synthetic thymosin beta-4 fragment referenced in preclinical tissue repair research Retatrutide GLP-3 multi-receptor agonist peptide for metabolic pathway laboratory studies Semaglutide GLP-1 GLP-1 receptor agonist for receptor binding and signaling research MOTS-C mitochondrial-derived peptide for cellular metabolism research applications View the complete research compounds catalog for additional lyophilized peptides with batch documentation
US$ 26.77
/assets/production/practices/91a656dbaed06a839d929dd58fbbd646e53f5ef7/images/2755432.jpeg)
US$ 26.62
US$ 20.74
US$ 26.42
US$ 24.84
